Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance

The dismal lethality of lung cancer is due to late stage at diagnosis and inherent therapeutic resistance. The incorporation of targeted therapies has modestly improved clinical outcomes, but the identification of new targets could further improve clinical outcomes by guiding stratification of poor-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunyu, Elkahloun, Abdel G., Robertson, Matthew, Gills, Joell J., Tsurutani, Junji, Shih, Joanna H., Fukuoka, Junya, Hollander, M. Christine, Harris, Curtis C., Travis, William D., Jen, Jin, Dennis, Phillip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161069/
https://www.ncbi.nlm.nih.gov/pubmed/21887332
http://dx.doi.org/10.1371/journal.pone.0023849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161069/
https://www.ncbi.nlm.nih.gov/pubmed/21887332
http://dx.doi.org/10.1371/journal.pone.0023849

Ejemplares similares